Baxter International Inc. (BAX)

The bull path envisions accelerated supply chain streamlining that restores operating profitability toward sector benchmarks, enabling rapid debt repayment and multiple expansion. Under this outcome, shares reach $35.73 delivering a return of 56.7% with a probability of 25.0%. Confirmation would appear through consecutive quarterly margin beats.

• Operating margin recovery accelerates toward broader medical technology industry benchmarks.
• Robust free cash flow generation accelerates balance sheet deleveraging without equity dilution.
• International market expansion in emerging hospital systems outpaces mature market replacement rates.